Société Générale — M&A Activity 2021

Apr 7, 2021

National Storage Mechanism | Additional information

RNS Number : 6762U

Societe Generale SA

07 April 2021

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.       KEY INFORMATION

Name of person dealing (Note 1)	Société Générale S.A.
Company dealt in	Willis Towers Watson plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	US$0.000304635 ordinary shares
Date of dealing	06/04/2021

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
Number	(%)	Number	(%)
(1) Relevant securities	883,394	0.68	2,626	0.00
(2) Derivatives (other than options)	1,136	0.00	587,906	0.46
(3) Options and agreements to purchase/sell	0	0.00	0	0.00
Total	*1,170,848	*0.91	590,532	0.46

* Include the holding of shares 286,318 on borrow products

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1.       DEALINGS (Note 4)

(a)      Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit USD (Note 5)
Purchase	108	236.78
Purchase	5	235.36
Purchase	6	235.45
Purchase	94	235.45
Purchase	21	236.08
Purchase	79	236.08
Purchase	1	235.58
Purchase	92	235.78
Purchase	8	235.78
Purchase	97	236.45
Purchase	2	236.41
Purchase	35	235.59
Purchase	3	236.45
Purchase	75	236.41
Purchase	46	235.59
Purchase	19	235.59
Purchase	100	236.32
Purchase	28	236.05
Purchase	22	236.05
Purchase	50	236.05
Purchase	19	235.57
Purchase	2	236.33
Purchase	100	235.44
Purchase	100	236.25
Purchase	100	235.77
Purchase	4	235.49
Purchase	11	235.49
Purchase	307	236.78
Purchase	91	235.99
Purchase	9	235.99
Purchase	1	235.48
Purchase	2	235.56
Purchase	1	235.56
Purchase	1	235.56
Purchase	456	235.65
Purchase	522	235.65
Purchase	1	234.72
Purchase	17	235.31
Purchase	20	234.66
Purchase	20	234.66
Purchase	100	234.74
Purchase	1	235.31
Purchase	65	234.78
Purchase	33	234.66
Purchase	27	234.66
Purchase	35	234.78
Purchase	11	235
Purchase	7	234.72
Purchase	89	235
Purchase	20	234.05
Purchase	8	235.7
Purchase	92	235.7
Purchase	5	235.22
Purchase	95	235.22
Purchase	5	234.96
Purchase	1	234.96
Purchase	91	234.96
Purchase	3	234.96
Purchase	41	235.15
Purchase	59	235.15
Purchase	100	235.15
Purchase	97	234.44
Purchase	3	234.44
Purchase	100	235.22
Purchase	100	234.8
Purchase	50	235.26
Purchase	5	235.26
Purchase	7	235.26
Purchase	26	235.26
Purchase	2	235.26
Purchase	10	235.26
Purchase	2	235.44
Purchase	98	235.44
Purchase	50	235.06
Purchase	50	235.06
Purchase	25	235.32
Purchase	75	235.32
Purchase	5	235.33
Purchase	3	235.33
Purchase	3	235.33
Purchase	4	234.91
Purchase	5	234.95
Purchase	100	235.49
Purchase	18	235.31
Purchase	37	235.51
Purchase	63	235.51
Purchase	14	235.31
Purchase	9	235.31
Purchase	59	235.31
Purchase	24	234.95
Purchase	57	234.05
Purchase	38	234.05
Purchase	2	234.05
Purchase	495	235.65
Purchase	185	235.65
Purchase	100	235.65
Sale	54	236.78
Sale	100	235.72
Sale	30	235.12
Sale	15	235.02
Sale	33	235.02
Sale	28	235.49
Sale	27	236.04
Sale	14	235.56
Sale	14	235.58
Sale	4	236.77
Sale	100	236.78
Sale	114	235.36
Sale	19	235.36
Sale	81	235.36
Sale	152	235.36
Sale	187	236.78
Sale	1,064	236.78
Sale	760	236.78
Sale	988	235.65
Sale	988	235.65
Sale	9	234.58
Sale	10	234.23
Sale	12	235.15
Sale	12	235.15
Sale	16	235.22
Sale	32	235
Sale	19	235.15
Sale	17	235.15
Sale	20	235.22
Sale	2	235.15
Sale	22	234.66
Sale	13	234.72
Sale	6	235.64
Sale	32	234.79
Sale	5	234.79
Sale	10	234.79
Sale	3	234.79
Total Purchases	5,484
Total Sales	5,012

Derivatives transactions (other than options transactions)

Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit USD (Note 5)

(b)      Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)

(ii)      Exercising

Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(c)      Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap21

2.       OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any 

relevant securities to which any derivative referred to on this form is referenced. 

If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            No

Date of disclosure	07/04/2021
Contact name	Société Générale - Disclosure team
Telephone number	+33 1 42 14 92 74
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEFIFVASIIDIIL